Summary of meetings

The AMC Secretariat is in close contact with the IAC, providing regular updates on progress of project implementation.

16 April 2010: AMC Eligibility Determination Meeting
An AMC Eligibility Determination Meeting was scheduled on 16th April 2010 to review GSK's application for AMC Eligibility. The IAC members unanimously determined that GSK Synflorix 2 dose presentation vaccine meets all of the TPP criteria and that the candidate vaccine is therefore eligible for purchase pursuant to the terms and conditions of the AMC for Pneumococcal disease. See Summary of meeting.

July and August 2009: Induction Calls
Following the signature of the legal agreements in June, the AMC Secretariat organised two induction calls on 14 July 2009 and on 10 August 2009 for IAC members to ensure that the committee was clear on its roles and responsibilities and related procedures as well as on the functioning of the AMC programme.

November and December 2008 - Endorsement of the Target Product Profile
In addition, the IAC first met by teleconference on 3 November 2008 to review and deliberate about the Pneumococcal AMC Target Product Profile (TPP). See Summary of meeting.

The IAC met again on 11 December 2008 to endorse the TPP. See Summary of meeting.

Summary of meetings

Related Documents